Osteopontin activates mesenchymal stem cells to repair skin wound

PLoS ONE

Volumn 12, Issue 9, 2017, Pages

  Wang, Wenping ^a   Li, Pei ^b   Li, Wei ^c   Jiang, Junzi ^a   Cui, Yanyan ^d   Li, Shirong ^a   Wang, Zhenxiang ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

^b No89 Hospital of People s Liberation Army   (China)

^c BENGBU MEDICAL COLLEGE   (China)

^d CHONGQING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; HERMES ANTIGEN; OSTEOPONTIN; RECOMBINANT PROTEIN; CD31 ANTIGEN; CYTOKERATIN 14; GREEN FLUORESCENT PROTEIN; VON WILLEBRAND FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL ACTIVATION; CELL DIFFERENTIATION; CELL INTERACTION; CELL LINEAGE; CELL MIGRATION; CELLS BY BODY ANATOMY; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; IN VITRO STUDY; KERATINOCYTE; KNOCKOUT MOUSE; MESENCHYMAL STEM CELL; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; SKIN INJURY; WOUND CLOSURE; WOUND HEALING; ANIMAL; C57BL MOUSE; CELL MOTION; CELL SEPARATION; CYTOLOGY; DEFICIENCY; DRUG EFFECTS; FLUORESCENT ANTIBODY TECHNIQUE; INJURIES; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY; SKIN;

ANIMALS; ANTIGENS, CD31; ANTIGENS, CD44; CELL DIFFERENTIATION; CELL MOVEMENT; CELL SEPARATION; DOWN-REGULATION; E-SELECTIN; ENDOTHELIAL CELLS; FLUORESCENT ANTIBODY TECHNIQUE; GREEN FLUORESCENT PROTEINS; KERATIN-14; KERATINOCYTES; MALE; MESENCHYMAL STROMAL CELLS; MICE, INBRED C57BL; OSTEOPONTIN; RECOMBINANT PROTEINS; SKIN; VON WILLEBRAND FACTOR; WOUND HEALING;

EID: 85030028613     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0185346     Document Type: Article

References (40)

1. Bruder SP, Fink DJ, Caplan AI. Mesenchymal stem cells in bone development, bone repair, and skeletal regeneration therapy. Journal of cellular biochemistry. 1994; 56: 283–94. https://doi.org/10.1002/jcb.240560303 PMID: 7876320
2. Sasaki M, Abe R, Fujita Y, Ando S, Inokuma D, Shimizu H. Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type. Journal of immunology (Baltimore, Md: 1950). 2008; 180: 2581–7.
3. Reyes M, Dudek A, Jahagirdar B, Koodie L, Marker PH, Verfaillie CM. Origin of endothelial progenitors in human postnatal bone marrow. The Journal of clinical investigation. 2002; 109: 337–46. https://doi.org/10.1172/JCI14327 PMID: 11827993
4. Kang SK, Putnam LA, Ylostalo J, Popescu IR, Dufour J, Belousov A, et al. Neurogenesis of Rhesus adipose stromal cells. Journal of cell science. 2004; 117: 4289–99. https://doi.org/10.1242/jcs.01264 PMID: 15292397
5. Tropel P, Platet N, Platel JC, Noel D, Albrieux M, Benabid AL, et al. Functional neuronal differentiation of bone marrow-derived mesenchymal stem cells. Stem cells. 2006; 24: 2868–76. https://doi.org/10.1634/stemcells.2005-0636 PMID: 16902198
6. Sato Y, Araki H, Kato J, Nakamura K, Kawano Y, Kobune M, et al. Human mesenchymal stem cells xenografted directly to rat liver are differentiated into human hepatocytes without fusion. Blood. 2005; 106: 756–63. https://doi.org/10.1182/blood-2005-02-0572 PMID: 15817682
7. Sgodda M, Aurich H, Kleist S, Aurich I, Konig S, Dollinger MM, et al. Hepatocyte differentiation of mesenchymal stem cells from rat peritoneal adipose tissue in vitro and in vivo. Experimental cell research. 2007; 313: 2875–86. https://doi.org/10.1016/j.yexcr.2007.05.020 PMID: 17574236
8. Jiang Y, Jahagirdar BN, Reinhardt RL, Schwartz RE, Keene CD, Ortiz-Gonzalez XR, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002; 418: 41–9. https://doi.org/10.1038/nature00870 PMID: 12077603
9. Aggarwal S, Pittenger MF. Human mesenchymal stem cells modulate allogeneic immune cell responses. Blood. 2005; 105: 1815–22. https://doi.org/10.1182/blood-2004-04-1559 PMID: 15494428
10. Gebler A, Zabel O, Seliger B. The immunomodulatory capacity of mesenchymal stem cells. Trends in molecular medicine. 2012; 18: 128–34. https://doi.org/10.1016/j.molmed.2011.10.004 PMID: 22118960
11. Mazzini L, Mareschi K, Ferrero I, Vassallo E, Oliveri G, Boccaletti R, et al. Autologous mesenchymal stem cells: clinical applications in amyotrophic lateral sclerosis. Neurological research. 2006; 28: 523–6. https://doi.org/10.1179/016164106X116791 PMID: 16808883
12. Moviglia GA, Fernandez Vina R, Brizuela JA, Saslavsky J, Vrsalovic F, Varela G, et al. Combined protocol of cell therapy for chronic spinal cord injury. Report on the electrical and functional recovery of two patients. Cytotherapy. 2006; 8: 202–9. https://doi.org/10.1080/14653240600736048 PMID: 16793729
13. Paquet-Fifield S, Schluter H, Li A, Aitken T, Gangatirkar P, Blashki D, et al. A role for pericytes as micro-environmental regulators of human skin tissue regeneration. The Journal of clinical investigation. 2009; 119: 2795–806. https://doi.org/10.1172/JCI38535 PMID: 19652362
14. Maxson S, Lopez EA, Yoo D, Danilkovitch-Miagkova A, Leroux MA. Concise review: role of mesenchymal stem cells in wound repair. Stem cells translational medicine. 2012; 1: 142–9. https://doi.org/10.5966/sctm.2011-0018 PMID: 23197761
15. Nuschke A. Activity of mesenchymal stem cells in therapies for chronic skin wound healing. Organogen-esis. 2014; 10: 29–37. https://doi.org/10.4161/org.27405 PMID: 24322872
16. Rowe PS. Molecular biology of hypophosphataemic rickets and oncogenic osteomalacia. Human genetics. 1994; 94: 457–67. PMID: 7959677
17. Denhardt DT, Burger EH, Kazanecki C, Krishna S, Semeins CM, Klein-Nulend J. Osteopontin-deficient bone cells are defective in their ability to produce NO in response to pulsatile fluid flow. Biochemical and biophysical research communications. 2001; 288: 448–53. https://doi.org/10.1006/bbrc.2001.5780 PMID: 11606063
18. Apte UM, Banerjee A, McRee R, Wellberg E, Ramaiah SK. Role of osteopontin in hepatic neutrophil infiltration during alcoholic steatohepatitis. Toxicology and applied pharmacology. 2005; 207: 25–38. https://doi.org/10.1016/j.taap.2004.12.018 PMID: 15885730
19. Banerjee A, Apte UM, Smith R, Ramaiah SK. Higher neutrophil infiltration mediated by osteopontin is a likely contributing factor to the increased susceptibility of females to alcoholic liver disease. The Journal of pathology. 2006; 208: 473–85. https://doi.org/10.1002/path.1917 PMID: 16440289
20. Denhardt DT, Mistretta D, Chambers AF, Krishna S, Porter JF, Raghuram S, et al. Transcriptional regulation of osteopontin and the metastatic phenotype: evidence for a Ras-activated enhancer in the human OPN promoter. Clinical & experimental metastasis. 2003; 20: 77–84.
21. El-Tanani MK, Campbell FC, Kurisetty V, Jin D, McCann M, Rudland PS. The regulation and role of osteopontin in malignant transformation and cancer. Cytokine & growth factor reviews. 2006; 17: 463–74.
22. Ramaiah SK, Rittling S. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer. Toxicological sciences: an official journal of the Society of Toxicology. 2008; 103: 4–13.
23. Al-Shami R, Sorensen ES, Ek-Rylander B, Andersson G, Carson DD, Farach-Carson MC. Phosphory-lated osteopontin promotes migration of human choriocarcinoma cells via a p70 S6 kinase-dependent pathway. Journal of cellular biochemistry. 2005; 94: 1218–33. https://doi.org/10.1002/jcb.20379 PMID: 15696579
24. Sodek J, Ganss B, McKee MD. Osteopontin. Critical reviews in oral biology and medicine: an official publication of the American Association of Oral Biologists. 2000; 11: 279–303.
25. Rittling SR. Osteopontin in macrophage function. Expert reviews in molecular medicine. 2011; 13: e15. https://doi.org/10.1017/S1462399411001839 PMID: 21545755
26. Liaw L, Birk DE, Ballas CB, Whitsitt JS, Davidson JM, Hogan BL. Altered wound healing in mice lacking a functional osteopontin gene (spp1). The Journal of clinical investigation. 1998; 101: 1468–78.
27. Mori R, Shaw TJ, Martin P. Molecular mechanisms linking wound inflammation and fibrosis: knockdown of osteopontin leads to rapid repair and reduced scarring. The Journal of experimental medicine. 2008; 205: 43–51. https://doi.org/10.1084/jem.20071412 PMID: 18180311
28. Dezawa M, Kanno H, Hoshino M, Cho H, Matsumoto N, Itokazu Y, et al. Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation. The Journal of clinical investigation. 2004; 113: 1701–10. https://doi.org/10.1172/JCI20935 PMID: 15199405
29. de la Fuente R, Bernad A, Garcia-Castro J, Martin MC, Cigudosa JC. Retraction: Spontaneous human adult stem cell transformation. Cancer research. 2010; 70: 6682. https://doi.org/10.1158/0008-5472.CAN-10-2451 PMID: 20710046
30. Kawada H, Fujita J, Kinjo K, Matsuzaki Y, Tsuma M, Miyatake H, et al. Nonhematopoietic mesenchymal stem cells can be mobilized and differentiate into cardiomyocytes after myocardial infarction. Blood. 2004; 104: 3581–7. https://doi.org/10.1182/blood-2004-04-1488 PMID: 15297308
31. Steck E, Bertram H, Abel R, Chen B, Winter A, Richter W. Induction of intervertebral disc-like cells from adult mesenchymal stem cells. Stem cells. 2005; 23: 403–11. https://doi.org/10.1634/stemcells.2004-0107 PMID: 15749935
32. Mahdavishahri N, Moghatam Matin M, Fereidoni M, Yarjanli Z, Banihashem Rad SA, Khajeh Ahmadi S. In vitro Assay of Human Gingival Scaffold in Differentiation of Rat’s Bone Marrow Mesenchymal Stem Cells to Keratinocystes. Iranian journal of basic medical sciences. 2012; 15: 1185–90. PMID: 23653849
33. Doan CC, Le TL, Hoang NS, Doan NT, Le VD, Do MS. Differentiation of umbilical cord lining membrane-derived mesenchymal stem cells into endothelial-like cells. Iranian biomedical journal. 2014; 18: 67–75. https://doi.org/10.6091/ibj.1261.2013 PMID: 24518546
34. Wang Q, Zhang W, He G, Sha H, Quan Z. Method for in vitro differentiation of bone marrow mesenchymal stem cells into endothelial progenitor cells and vascular endothelial cells. Molecular medicine reports. 2016; 14: 5551–5. https://doi.org/10.3892/mmr.2016.5953 PMID: 27878275
35. Anjos-Afonso F, Siapati EK, Bonnet D. In vivo contribution of murine mesenchymal stem cells into multiple cell-types under minimal damage conditions. Journal of cell science. 2004; 117: 5655–64. https://doi.org/10.1242/jcs.01488 PMID: 15494370
36. Khan SA, Cook AC, Kappil M, Gunthert U, Chambers AF, Tuck AB, et al. Enhanced cell surface CD44 variant (v6, v9) expression by osteopontin in breast cancer epithelial cells facilitates tumor cell migration: novel post-transcriptional, post-translational regulation. Clinical & experimental metastasis. 2005; 22: 663–73.
37. Weber GF, Ashkar S, Glimcher MJ, Cantor H. Receptor-ligand interaction between CD44 and osteopontin (Eta-1). Science (New York, NY). 1996; 271: 509–12.
38. Katayama Y, Hidalgo A, Chang J, Peired A, Frenette PS. CD44 is a physiological E-selectin ligand on neutrophils. The Journal of experimental medicine. 2005; 201: 1183–9. https://doi.org/10.1084/jem.20042014 PMID: 15824084
39. Standal T, Borset M, Sundan A. Role of osteopontin in adhesion, migration, cell survival and bone remodeling. Experimental oncology. 2004; 26: 179–84. PMID: 15494684
40. Sackstein R, Merzaban JS, Cain DW, Dagia NM, Spencer JA, Lin CP, et al. Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone. Nature medicine. 2008; 14: 181–7. https://doi.org/10.1038/nm1703 PMID: 18193058